Ray Therapeutics

raytherapeutics.com

Ray Therapeutics is focused on developing transformative optogenetic gene therapies aimed at restoring vision for patients suffering from blinding diseases, particularly retinitis pigmentosa and other ocular diseases. The company leverages advanced technology to study rare retinal diseases, enabling innovative treatment options that differentiate it in the market. With a commitment to equity, diversity, and inclusion, Ray Therapeutics fosters a collaborative environment to attract and retain top talent, which is crucial for their growth and success in the competitive biotech landscape.